Cardiovascular and oncology

Recent Articles

RELATED ARTICLES

  1. This pharmaceutical company posted an 11% rise in half-year revenue, helped by growing income from innovative medicines, as it pivots away from the generic drug business.
    Novel drugs lift Sino Biopharm earnings, easing price-cap pain
    1177.HK
  2. CSPC Pharma weighs up diet drug for bigger bottom line
    1093.HK
  3. So-Young dolls up with pivot to high-end services
    SY.US
  4. Profit setback for Simcere Pharma in novel drugs quest
    2096.HK
  5. CSPC Pharma taps R&D superstar in quest for new breakout drugs
    1093.HK
  6. Jiuyuan Gene seeks IPO cash for bet on weight-loss drugs
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva